ADH300004

DRUG3 trials

Sponsors

Adherex Technologies, Inc.

Conditions

Hepatocellular CarcinomaNeoplasms

Phase 1

A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection

CompletedNCT00264446

Adherex Technologies, Inc.Neoplasms

Updated: 2007-08-06

A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

SuspendedNCT00264472

Adherex Technologies, Inc.Neoplasms

Start: 2006-01-31Target: 60Updated: 2008-12-15

A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

TerminatedNCT00319683

Adherex Technologies, Inc.Hepatocellular Carcinoma

Updated: 2008-12-15